The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

A bispecific antibody that simultaneously targets PD-1 and VEGF extended overall survival by more than four months compared ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...

The Andes virus, the germ behind the cruise ship outbreak, is a particular focus of researchers because it is the only ...

A cruise ship outbreak made the world aware of hantavirus. Scientists want to use this new fame - There were no treatments or ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...

First T cell therapy for a solid tumor cancer and first treatment option approved in Australia for advanced melanoma after anti-PD-1 and targeted therapy ...

Answers to key questions could help public health officials develop Ebola treatments, predict the outbreak’s trajectory and ...

Expanded collaboration builds upon research momentum in developing next-generation bispecific immunotherapies using CytomX’s ...

Transactions Provide Financial Flexibility to Advance Pipeline of Next Generation Cancer Therapies Comprised of Novel Bispecific T-cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs)Support Closi ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal ...

Fiercely self-assured, scientifically relentless, and unwilling to accept the limits imposed on women of her era, Rosalyn ...